Petros Pharmaceuticals, Inc. (PTPI)

NASDAQ: PTPI · Real-Time Price · USD
0.0860
-0.0250 (-22.52%)
At close: Mar 28, 2025, 4:00 PM
0.0800
-0.0060 (-6.98%)
After-hours: Mar 28, 2025, 7:57 PM EDT
-22.52%
Market Cap 2.57M
Revenue (ttm) 4.02M
Net Income (ttm) -19.85M
Shares Out 29.93M
EPS (ttm) -3.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,347,535
Open 0.0916
Previous Close 0.1110
Day's Range 0.0860 - 0.0964
52-Week Range 0.0540 - 1.4800
Beta 2.03
Analysts n/a
Price Target n/a
Earnings Date May 14, 2025

About PTPI

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men’s health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie’s disease. The company offers men’s health... [Read more]

Sector Healthcare
Founded 2020
Employees 21
Stock Exchange NASDAQ
Ticker Symbol PTPI
Full Company Profile

Financial Performance

In 2023, Petros Pharmaceuticals's revenue was $5.82 million, a decrease of -2.83% compared to the previous year's $5.99 million. Losses were -$13.81 million, -31.06% less than in 2022.

Financial Statements

News

NextTrip Launches New Innovative Online Cruise Booking Platform NextTrip Cruise

Next-Gen Platform Provides a Seamless End-to-End Cruise Booking Process for Travelers SANTA FE, NM / ACCESS Newswire / March 27, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "C...

Other symbols: NTRP
1 day ago - Accesswire

Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the coun...

8 days ago - Accesswire

NextTrip Strengthens Financial Position with the Conversion of $2.6 Million in Short-Term Debt to Restricted Equity Before its Fiscal Year-End

Provides for a Stronger Balance Sheet and Greater Financial Flexibility to Focus on Scaling Innovative Travel Solutions SANTA FE, NM / ACCESS Newswire / February 28, 2025 / NextTrip, Inc. (NASDAQ:NTRP...

Other symbols: NTRP
4 weeks ago - Accesswire

NextTrip and Blue Fysh Announce Strategic Partnership and Share Exchange Agreement to Drive Mutual Growth

Enables Expanded Audience Reach, Increased Advertising Revenue, Enhanced Sales Efforts, Increased Brand Awareness and Other Strategic Partnership Opportunities SUNRISE, FL / ACCESS Newswire / February...

Other symbols: NTRP
4 weeks ago - Accesswire

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Petros Pharmaceutic...

4 weeks ago - Accesswire

NextTrip Appoints John McMahon as Chief Operating Officer - Travel, Expands into Cruise Industry with Five Star Alliance

Proven Industry Leader Brings Deep Relationships and Extensive Expertise Across all Facets of Leisure, Travel and Tourism Five Star Alliance Now Directing Group Booking Inquiries to NextTrip NextTrip ...

Other symbols: NTRP
4 weeks ago - Accesswire

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-t...

5 weeks ago - Accesswire

NextTrip Closes on 49% Stake in Five Star Alliance

Secures Option to Acquire Full Ownership SANTA FE, NM / ACCESS Newswire / February 11, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip" or the "Company"), a leading travel technology company, today ann...

Other symbols: NTRP
6 weeks ago - Accesswire

NextTrip Invests in Luxury Travel Brand Five Star Alliance to secure 49% Stake with an Option to Purchase a Controlling Interest

Transaction Expected to Strengthen NextTrip's Platform, Unlocks New Integration and Growth Opportunities Five Star Senior Management to Join NextTrip to Help Define Key Areas of Synergy and Revenue Ac...

Other symbols: NTRP
7 weeks ago - Accesswire

Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules

Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros Pharma...

2 months ago - Accesswire

Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”

Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceutic...

3 months ago - Accesswire

Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually

Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications NEW YORK,...

3 months ago - Accesswire

NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group

NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, today announced the official launch of advertising on its travel discovery channel, Compa...

Other symbols: NTRP
4 months ago - Accesswire

NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance

One of Trustpilot's Top-rated Travel Brands Brings its Proprietary Search Engine, Luxury Cruise Program, and Group Travel Pipeline, Along with Access to Additional Travel Agencies Acquisition is Highl...

Other symbols: NTRP
5 months ago - Accesswire

NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators

Seamlessly Translates Content into Commerce Opportunities using the NextTrip Booking Engine SANTA FE, NM / ACCESSWIRE / October 1, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the ...

Other symbols: NTRP
6 months ago - Accesswire

Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Company is currently conducting larger scale comprehension test to confirm results in compliance with FDA discussions NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Petros Pharmaceuticals, Inc. (NAS...

7 months ago - Accesswire

Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter ("OTC") drug developm...

7 months ago - Accesswire

NextTrip Introduces Group Booking Technology Platform to Streamline and Simplify Travel for Groups

New Flexible Solution Designed to Reduce Friction, Empowering Customers When Reserving Group Travel SUNRISE, FL / ACCESSWIRE / July 30, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or...

Other symbols: NTRP
8 months ago - Accesswire

Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts t...

8 months ago - Accesswire

NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements

SUNRISE, FL / ACCESSWIRE / July 19, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, received a notice (the "Notice") from the listing qual...

Other symbols: NTRP
9 months ago - Accesswire

NextTrip Taps Dooya Media Group To Launch Compass.TV

Dynamic Content-to-Commerce FAST Channel Reinvents Monetization Models SUNRISE, FL / ACCESSWIRE / July 18, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel tec...

Other symbols: NTRP
9 months ago - Accesswire

Petros Pharmaceuticals' STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance

Vital study aligned with FDA guidelines shows encouraging performance as Petros continues close FDA contact for a potential technology-centered Rx-to-OTC switch NEW YORK, NY / ACCESSWIRE / July 16, 20...

9 months ago - Accesswire

NextTrip Launches FlexPay Travel Payment Options for Bookings

Allows Consumers to Pay for Accommodations Through Interest-free Installments with Convenient and Flexible Payment Options when Booking Travel Seamless Integration Enables Marketing Opportunities in S...

Other symbols: NTRP
9 months ago - Accesswire

NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements

SUNRISE, FL / ACCESSWIRE / June 21, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has received a notice (the "Notice") from the listing ...

Other symbols: NTRP
10 months ago - Accesswire

Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe

Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only) [1] Ple...

Other symbols: ME
11 months ago - Accesswire